Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (15), 1041-1047
- https://doi.org/10.1016/s1359-6446(05)03512-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor ActivityJournal of Biological Chemistry, 2005
- In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate TumorsClinical Cancer Research, 2005
- Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871Clinical Cancer Research, 2005
- The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of ChemotherapyClinical Cancer Research, 2005
- A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenograftsInternational Journal of Cancer, 2004
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Combined Effects of Tamoxifen and a Chimeric Humanized Single Chain Antibody against the Type I IGF Receptor on Breast Tumor GrowthIn vivoHormone and Metabolic Research, 2003
- Crystal Structure of the Apo, Unactivated Insulin-like Growth Factor-1 Receptor KinaseJournal of Biological Chemistry, 2002
- The contradictions of the insulin-like growth factor 1 receptorOncogene, 2000
- Two New Monoclonal Antibodies against the α Subunit of the Human Insulin-like Growth Factor-I ReceptorBiochemical and Biophysical Research Communications, 1993